Company intelligence
Amphix Bio
Developing the Next Generation of Peptide Therapeutics
Biotechnology Research
Chicago, US
9 employees
1 public signals
About Amphix Bio
Amphix Bio is a preclinical stage company developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging. These therapies trigger targeted signaling pathways while forming scaffolds to support biological repair. Amphix Bio's goal is to increase human healthspan — the length of time that people can live productive, fulfilling lives.
Verified activity
Signals from Amphix Bio
1 published signal